Comment on "Dextromethorphan-induced serotonin syndrome".
Karamanakos
Petros Nikolaos
PN
Panteli
Eleftheria Spyridon
ES
D002744:Chlorpheniramine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003915:Dextromethorphan / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D020230:Serotonin Syndrome / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D002744:Chlorpheniramine; D003915:Dextromethorphan; D006634:Histamine H1 Antagonists; D017367:Selective Serotonin Reuptake Inhibitors